Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection

Anjali Sharma, Donald R. Hoover, Qiuhu Shi, Jennie C.I. Tsao, Christopher Cox, Deborah R. Gustafson, Kathleen Weber, Ruth M. Greenblatt, Bradley E. Aouizerat, Michael W. Plankey

Research output: Contribution to journalArticle

Abstract

Pain is frequent and underreported among HIV+ women. We determined occurrence and severity of pain, and types of pain treatments used among HIV+ and HIV− women. Cross-sectional analyses of pain as measured by the Brief Pain Inventory Short Form, and related pain therapies nested in the Women’s Interagency HIV Study (WIHS). Multiple variable linear regression models examined differences by HIV status in pain severity and pain interference in general activity, mood, ability to walk, work, relationships with others, sleep, and enjoyment of life. Among 1393 HIV+ and 587 HIV− participants with median age 47–48 years, there was no statistically significant difference in pain reported within the past week by HIV status (HIV+ 50% vs. 49% HIV−, p = 0.70). Ratings of pain severity and interference were similar between HIV+ and HIV− women, as was receipt of pain medication (58% HIV+ vs. 56% HIV−). Pain medications most frequently used were: NSAIDS (90% HIV+, 96% HIV−), opioids (65% HIV+, 67% HIV−), topical anesthetics (46% HIV+, 56% HIV−), muscle relaxants (23% HIV+, 14% HIV−), and anticonvulsants (23% HIV+, 14% HIV−). Nearly half of predominantly low income, minority women reported pain in the past week, and two-thirds reported opioid use for pain management. The occurrence, severity, and treatment of pain did not differ by HIV status, nor did report of pain interference with mood or function. Additional research is needed to better characterize pain etiology among HIV+ women in the era of potent antiretroviral therapy, and determine the extent to which pain severity and type of medication used for pain treatment impact HIV disease outcomes.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalAIDS and Behavior
DOIs
StateAccepted/In press - Jun 19 2017

Fingerprint

Opioid Analgesics
HIV Infections
Prescriptions
HIV
Pain
Therapeutics
Linear Models

Keywords

  • HIV
  • Opioid
  • Pain
  • Women

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection. / Sharma, Anjali; Hoover, Donald R.; Shi, Qiuhu; Tsao, Jennie C.I.; Cox, Christopher; Gustafson, Deborah R.; Weber, Kathleen; Greenblatt, Ruth M.; Aouizerat, Bradley E.; Plankey, Michael W.

In: AIDS and Behavior, 19.06.2017, p. 1-10.

Research output: Contribution to journalArticle

Sharma, A, Hoover, DR, Shi, Q, Tsao, JCI, Cox, C, Gustafson, DR, Weber, K, Greenblatt, RM, Aouizerat, BE & Plankey, MW 2017, 'Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection', AIDS and Behavior, pp. 1-10. https://doi.org/10.1007/s10461-017-1828-0
Sharma, Anjali ; Hoover, Donald R. ; Shi, Qiuhu ; Tsao, Jennie C.I. ; Cox, Christopher ; Gustafson, Deborah R. ; Weber, Kathleen ; Greenblatt, Ruth M. ; Aouizerat, Bradley E. ; Plankey, Michael W. / Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection. In: AIDS and Behavior. 2017 ; pp. 1-10.
@article{bfb03839b7cf4727b8e7e145f1a3d73b,
title = "Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection",
abstract = "Pain is frequent and underreported among HIV+ women. We determined occurrence and severity of pain, and types of pain treatments used among HIV+ and HIV− women. Cross-sectional analyses of pain as measured by the Brief Pain Inventory Short Form, and related pain therapies nested in the Women’s Interagency HIV Study (WIHS). Multiple variable linear regression models examined differences by HIV status in pain severity and pain interference in general activity, mood, ability to walk, work, relationships with others, sleep, and enjoyment of life. Among 1393 HIV+ and 587 HIV− participants with median age 47–48 years, there was no statistically significant difference in pain reported within the past week by HIV status (HIV+ 50{\%} vs. 49{\%} HIV−, p = 0.70). Ratings of pain severity and interference were similar between HIV+ and HIV− women, as was receipt of pain medication (58{\%} HIV+ vs. 56{\%} HIV−). Pain medications most frequently used were: NSAIDS (90{\%} HIV+, 96{\%} HIV−), opioids (65{\%} HIV+, 67{\%} HIV−), topical anesthetics (46{\%} HIV+, 56{\%} HIV−), muscle relaxants (23{\%} HIV+, 14{\%} HIV−), and anticonvulsants (23{\%} HIV+, 14{\%} HIV−). Nearly half of predominantly low income, minority women reported pain in the past week, and two-thirds reported opioid use for pain management. The occurrence, severity, and treatment of pain did not differ by HIV status, nor did report of pain interference with mood or function. Additional research is needed to better characterize pain etiology among HIV+ women in the era of potent antiretroviral therapy, and determine the extent to which pain severity and type of medication used for pain treatment impact HIV disease outcomes.",
keywords = "HIV, Opioid, Pain, Women",
author = "Anjali Sharma and Hoover, {Donald R.} and Qiuhu Shi and Tsao, {Jennie C.I.} and Christopher Cox and Gustafson, {Deborah R.} and Kathleen Weber and Greenblatt, {Ruth M.} and Aouizerat, {Bradley E.} and Plankey, {Michael W.}",
year = "2017",
month = "6",
day = "19",
doi = "10.1007/s10461-017-1828-0",
language = "English (US)",
pages = "1--10",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",

}

TY - JOUR

T1 - Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain Among Women with and at Risk for HIV Infection

AU - Sharma, Anjali

AU - Hoover, Donald R.

AU - Shi, Qiuhu

AU - Tsao, Jennie C.I.

AU - Cox, Christopher

AU - Gustafson, Deborah R.

AU - Weber, Kathleen

AU - Greenblatt, Ruth M.

AU - Aouizerat, Bradley E.

AU - Plankey, Michael W.

PY - 2017/6/19

Y1 - 2017/6/19

N2 - Pain is frequent and underreported among HIV+ women. We determined occurrence and severity of pain, and types of pain treatments used among HIV+ and HIV− women. Cross-sectional analyses of pain as measured by the Brief Pain Inventory Short Form, and related pain therapies nested in the Women’s Interagency HIV Study (WIHS). Multiple variable linear regression models examined differences by HIV status in pain severity and pain interference in general activity, mood, ability to walk, work, relationships with others, sleep, and enjoyment of life. Among 1393 HIV+ and 587 HIV− participants with median age 47–48 years, there was no statistically significant difference in pain reported within the past week by HIV status (HIV+ 50% vs. 49% HIV−, p = 0.70). Ratings of pain severity and interference were similar between HIV+ and HIV− women, as was receipt of pain medication (58% HIV+ vs. 56% HIV−). Pain medications most frequently used were: NSAIDS (90% HIV+, 96% HIV−), opioids (65% HIV+, 67% HIV−), topical anesthetics (46% HIV+, 56% HIV−), muscle relaxants (23% HIV+, 14% HIV−), and anticonvulsants (23% HIV+, 14% HIV−). Nearly half of predominantly low income, minority women reported pain in the past week, and two-thirds reported opioid use for pain management. The occurrence, severity, and treatment of pain did not differ by HIV status, nor did report of pain interference with mood or function. Additional research is needed to better characterize pain etiology among HIV+ women in the era of potent antiretroviral therapy, and determine the extent to which pain severity and type of medication used for pain treatment impact HIV disease outcomes.

AB - Pain is frequent and underreported among HIV+ women. We determined occurrence and severity of pain, and types of pain treatments used among HIV+ and HIV− women. Cross-sectional analyses of pain as measured by the Brief Pain Inventory Short Form, and related pain therapies nested in the Women’s Interagency HIV Study (WIHS). Multiple variable linear regression models examined differences by HIV status in pain severity and pain interference in general activity, mood, ability to walk, work, relationships with others, sleep, and enjoyment of life. Among 1393 HIV+ and 587 HIV− participants with median age 47–48 years, there was no statistically significant difference in pain reported within the past week by HIV status (HIV+ 50% vs. 49% HIV−, p = 0.70). Ratings of pain severity and interference were similar between HIV+ and HIV− women, as was receipt of pain medication (58% HIV+ vs. 56% HIV−). Pain medications most frequently used were: NSAIDS (90% HIV+, 96% HIV−), opioids (65% HIV+, 67% HIV−), topical anesthetics (46% HIV+, 56% HIV−), muscle relaxants (23% HIV+, 14% HIV−), and anticonvulsants (23% HIV+, 14% HIV−). Nearly half of predominantly low income, minority women reported pain in the past week, and two-thirds reported opioid use for pain management. The occurrence, severity, and treatment of pain did not differ by HIV status, nor did report of pain interference with mood or function. Additional research is needed to better characterize pain etiology among HIV+ women in the era of potent antiretroviral therapy, and determine the extent to which pain severity and type of medication used for pain treatment impact HIV disease outcomes.

KW - HIV

KW - Opioid

KW - Pain

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85021083333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021083333&partnerID=8YFLogxK

U2 - 10.1007/s10461-017-1828-0

DO - 10.1007/s10461-017-1828-0

M3 - Article

SP - 1

EP - 10

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

ER -